Matsumoto identified tumor-specific blood ECs in a mouse glioma model, that originated from cells expressing the receptor for colony stimulating factor 1, Csf1r, (a cytokine that controls macrophage biology), demonstrating that these cells formed tumor vasculature and their selective depletion reduced vascular branching and tumor growth [100]. The gene discussed is CSF1R; the disease is glioma.